Ranfa Pharmaceuticals Private Limited

Ranfa Pharmaceuticals Private Limited - healthcare in Taltala, West Bengal, India. Directors, charges & compliance details.
CIN U33119WB2022PTC251285 Incorporated 01 February 2022 ROC Kolkata HQ Taltala, West Bengal, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹17.56 Lakh
▲ 149% YoY
Net profit · FY 2025
₹1.15 Lakh
Net margin 6.6%
EBITDA · FY 2025
₹1.56 Lakh
EBITDA margin 8.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ranfa Pharmaceuticals Private Limited

Data last updated:

Ranfa Pharmaceuticals Private Limited is a private limited company based in Taltala, West Bengal, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 01 February 2022.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33119WB2022PTC251285.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ariba Siddique and Mohd Nazrul Islam.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 41/2 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.56 Lakh, a growth of 149% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 6.6%) and EBITDA of ₹1.56 Lakh (EBITDA margin 8.9%).

Ranfa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-13-0035039). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33119WB2022PTC251285
Registration Number 251285
Incorporation Date 01 February 2022
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-13-0035039

Recognitions & Rankings of Ranfa Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-WB-13-0035039

Contact details

Ranfa Pharmaceuticals Private Limited's registered office is in Taltala, West Bengal.

  • Registered Address
    41/2 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014
  • Industry
    Healthcare, Manufacturing, Other Medical And Surgical Equipment, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments
Comprehensive company report
Ranfa Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ranfa Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ranfa Pharmaceuticals Private Limited, buy the company report.

Financials of Ranfa Pharmaceuticals Private Limited

FY 2025 filings available

Ranfa Pharmaceuticals Private Limited reported revenue of ₹17.56 Lakh (up 149% YoY) for FY 2025.

Revenue · FY 2025
₹17.56 Lakh ▲ 149%
Net profit · FY 2025
₹1.15 Lakh margin 6.6%
EBITDA · FY 2025
₹1.56 Lakh margin 8.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 149%
EBITDA CAGR growth
1 year
▲ 76%

Revenue rose 149% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.15 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin8.9%
Net Profit Margin6.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ranfa Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ranfa Pharmaceuticals Private Limited

Ranfa Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ariba SiddiqueDirector01 Feb 20224 Years 8 MonthsCurrent
Mohd Nazrul IslamDirector01 Feb 20224 Years 8 MonthsCurrent
Rubeda HamidDirector01 Feb 20224 Years 8 MonthsCurrent
Runi KhatunAdditional Director01 Apr 20233 Years 6 MonthsCurrent

Peer comparison

Ranfa Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Victomed Pharmaceuticals Private Limited₹17.58 Lakh (FY 2025)-2.0%Theni, Tamil Nadu, India
Bioscodex Pharmaceuticals Private Limited₹17.57 Lakh (FY 2019)93.0%Hyderabad, Telangana, India
Ranfa Pharmaceuticals Private Limitedthis company₹17.56 Lakh (FY 2025)₹1.15 Lakh6.6%149.0%Taltala, West Bengal, India
Agbro Pharmaceuticals Private Limited₹17.53 Lakh (FY 2021)-28.0%Bangalore, Karnataka, India
Indie Globe Pharmaceuticals Private Limited₹17.5 Lakh (FY 2016)9.0%New Delhi, Delhi, India

To see the full peer comparison of Ranfa Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ranfa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ranfa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ranfa Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Runi Khatun was appointed as Additional Director on 01 Apr 2023.

AGM
Ranfa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ranfa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Runi Khatun was appointed as Additional Director.
Appointed
Ariba Siddique was appointed as Director.
Appointed
Mohd Nazrul Islam was appointed as Director.
Appointed
Rubeda Hamid was appointed as Director.
Incorporation
01 Feb 2022
Ranfa Pharmaceuticals Private Limited was registered on 01 Feb 2022 with Roc Kolkata I & aged 4 years 8 months as per MCA records.

Frequently asked questions

Ranfa Pharmaceuticals is an active private limited company based in Taltala, West Bengal, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under CIN U33119WB2022PTC251285.

Ranfa Pharmaceuticals has 4 current directors:

The latest financial statements of Ranfa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Ranfa Pharmaceuticals is U33119WB2022PTC251285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ranfa Pharmaceuticals was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Ranfa Pharmaceuticals by revenue are Victomed Pharmaceuticals Private Limited, Bioscodex Pharmaceuticals Private Limited, Agbro Pharmaceuticals Private Limited, Indie Globe Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Runi Khatun was appointed as Additional Director on 01 Apr 2023. Ariba Siddique was appointed as Director on 01 Feb 2022. Mohd Nazrul Islam was appointed as Director on 01 Feb 2022. Ranfa Pharmaceuticals has 4 board changes on record in total.

Yes, Ranfa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-13-0035039).

The registered office of Ranfa Pharmaceuticals is at 412 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014.

Ranfa Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.

The compliance status of Ranfa Pharmaceuticals is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.